Linda L Garland, MD

Dr. Garland is a thoracic medical oncologist and translational researcher who has designed investigator-initiated translational clinical trials with novel targeted agents in advanced lung cancer and mesothelioma. She participates in chemoprevention efforts at the Cancer Center through serving as co-investigator and medical director of the N01-supported Cancer Center’s Cancer Prevention and Control Program and the PI on sequential NCI-funded lung cancer prevention trials. She participates in translational collaboration with several basic scientists in preclinical development of novel cancer agents and imaging biomarkers.

Further, Dr. Garland collaborates with University of Arizona Biomedical Engineering in serving as a co-investigator for a randomized trial of a novel exercise intervention for cancer patients with peripheral neuropathy that provides evidence of improved balance outcomes relevant to fall prevention with the novel exercise intervention.

Dr. Garland previously served for 10 years on the University of Arizona Institutional Review Board (IRB).